G
Gemadept Corp
VN:GMD
Gemadept Corp
VN:GMD
Price:
65 000
VND
Market Closed
Market Cap:
26.9T
VND
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
GMD Alert
Gemadept Corp
65000
0 (0%)
| 52 Week Range |
56 480.5762
72 072.8645
|
| Price Target |
|
We'll email you a reminder when the closing price reaches VND.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Gemadept Corp
Balance Sheet
Balance Sheet Decomposition
Gemadept Corp
Gemadept Corp
| Current Assets | 3.5T |
| Cash & Short-Term Investments | 1.8T |
| Receivables | 1.3T |
| Other Current Assets | 375.4B |
| Non-Current Assets | 10.9T |
| Long-Term Investments | 3.5T |
| PP&E | 5.4T |
| Intangibles | 376.4B |
| Other Non-Current Assets | 1.5T |
| Current Liabilities | 1.9T |
| Accounts Payable | 533.2B |
| Accrued Liabilities | 589.4B |
| Short-Term Debt | 55.8B |
| Other Current Liabilities | 764.1B |
| Non-Current Liabilities | 3.3T |
| Long-Term Debt | 1.5T |
| Other Non-Current Liabilities | 1.8T |
Balance Sheet
Gemadept Corp
Gemadept Corp
Currency: VND
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
943 318
|
904 519
|
724 470
|
779 802
|
172 567
|
185 546
|
427 676
|
637 349
|
1 364 350
|
1 471 554
|
|
| Cash |
462 812
|
329 701
|
374 695
|
494 938
|
152 567
|
181 546
|
416 176
|
430 774
|
733 409
|
761 886
|
|
| Cash Equivalents |
480 506
|
574 818
|
349 775
|
284 864
|
20 000
|
4 000
|
11 500
|
206 575
|
630 941
|
709 668
|
|
| Short-Term Investments |
596 436
|
91 442
|
88 716
|
113 000
|
112 265
|
44 268
|
23 437
|
51 832
|
82 230
|
358 867
|
|
| Total Receivables |
947 489
|
1 263 295
|
884 079
|
904 632
|
709 004
|
718 862
|
678 704
|
752 645
|
938 996
|
1 381 678
|
|
| Accounts Receivables |
335 282
|
394 098
|
515 754
|
606 009
|
405 797
|
358 161
|
332 464
|
426 328
|
530 637
|
549 795
|
|
| Other Receivables |
612 207
|
869 196
|
368 325
|
298 623
|
303 207
|
360 701
|
346 240
|
326 317
|
408 358
|
831 883
|
|
| Inventory |
91 266
|
107 208
|
87 030
|
107 801
|
65 548
|
78 381
|
72 967
|
68 713
|
82 532
|
68 170
|
|
| Other Current Assets |
273 674
|
311 603
|
359 239
|
317 882
|
332 093
|
160 713
|
153 615
|
178 941
|
150 619
|
99 810
|
|
| Total Current Assets |
2 852 183
|
2 678 067
|
2 143 533
|
2 223 117
|
1 391 477
|
1 187 770
|
1 356 400
|
1 689 479
|
2 618 727
|
3 380 201
|
|
| PP&E Net |
3 017 053
|
3 272 002
|
4 189 765
|
5 350 375
|
4 830 524
|
4 875 800
|
4 634 951
|
4 630 892
|
5 790 841
|
5 666 981
|
|
| PP&E Gross |
3 017 053
|
3 272 002
|
4 189 765
|
5 350 375
|
4 830 524
|
4 875 800
|
4 634 951
|
4 630 892
|
5 790 841
|
5 666 981
|
|
| Accumulated Depreciation |
1 423 302
|
1 659 446
|
1 788 675
|
2 016 953
|
1 629 330
|
2 016 364
|
2 278 375
|
2 576 030
|
2 926 183
|
2 562 605
|
|
| Intangible Assets |
6 506
|
245 886
|
331 428
|
315 899
|
281 139
|
269 277
|
265 287
|
261 733
|
261 600
|
258 390
|
|
| Goodwill |
193 674
|
160 281
|
126 887
|
93 494
|
55 300
|
296 753
|
241 531
|
213 928
|
186 324
|
158 721
|
|
| Note Receivable |
138 800
|
196 825
|
149 794
|
127 132
|
54 190
|
34 725
|
55 657
|
43 481
|
44 606
|
39 755
|
|
| Long-Term Investments |
1 490 250
|
2 010 258
|
2 308 318
|
2 310 195
|
2 631 526
|
2 684 481
|
2 531 074
|
2 830 079
|
3 065 415
|
3 124 651
|
|
| Other Long-Term Assets |
481 316
|
435 982
|
871 474
|
871 005
|
739 906
|
771 100
|
749 643
|
1 061 619
|
1 063 139
|
917 326
|
|
| Other Assets |
193 674
|
160 281
|
126 887
|
93 494
|
55 300
|
296 753
|
241 531
|
213 928
|
186 324
|
158 721
|
|
| Total Assets |
8 179 782
N/A
|
8 999 301
+10%
|
10 121 200
+12%
|
11 291 217
+12%
|
9 984 063
-12%
|
10 119 907
+1%
|
9 834 544
-3%
|
10 731 211
+9%
|
13 030 653
+21%
|
13 546 025
+4%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
358 991
|
579 710
|
595 038
|
761 273
|
403 580
|
422 801
|
357 899
|
380 603
|
838 451
|
517 924
|
|
| Accrued Liabilities |
207 238
|
383 778
|
538 016
|
465 092
|
274 512
|
284 698
|
345 108
|
572 698
|
361 616
|
507 492
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
396 826
|
283 910
|
422 941
|
521 830
|
177 454
|
63 359
|
|
| Current Portion of Long-Term Debt |
407 459
|
423 635
|
1 578 671
|
714 513
|
278 181
|
367 960
|
339 946
|
338 636
|
365 962
|
382 001
|
|
| Other Current Liabilities |
195 648
|
273 318
|
249 428
|
735 353
|
211 066
|
469 114
|
279 316
|
448 954
|
1 467 096
|
444 562
|
|
| Total Current Liabilities |
1 169 335
|
1 660 441
|
2 961 152
|
2 676 232
|
1 564 165
|
1 828 483
|
1 745 212
|
2 262 721
|
3 210 579
|
1 915 337
|
|
| Long-Term Debt |
1 480 320
|
1 455 293
|
927 559
|
1 220 610
|
1 591 981
|
1 425 617
|
1 137 739
|
1 061 244
|
1 486 163
|
1 518 388
|
|
| Deferred Income Tax |
12 330
|
11 438
|
9 892
|
6 567
|
230 489
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
341 081
|
525 365
|
700 476
|
750 972
|
648 709
|
691 497
|
693 430
|
725 658
|
1 021 704
|
1 151 889
|
|
| Other Liabilities |
298 735
|
312 404
|
352 700
|
293 271
|
68 446
|
298 550
|
356 664
|
362 628
|
386 155
|
379 926
|
|
| Total Liabilities |
3 301 801
N/A
|
3 964 940
+20%
|
4 951 779
+25%
|
4 947 652
0%
|
4 103 789
-17%
|
4 244 147
+3%
|
3 933 045
-7%
|
4 412 250
+12%
|
6 104 601
+38%
|
4 965 540
-19%
|
|
| Equity | |||||||||||
| Common Stock |
1 161 380
|
1 196 220
|
1 794 323
|
2 882 770
|
2 969 250
|
2 969 250
|
3 013 780
|
3 013 780
|
3 013 780
|
3 058 986
|
|
| Retained Earnings |
1 031 154
|
1 101 389
|
1 134 111
|
1 113 091
|
541 644
|
505 388
|
435 146
|
661 220
|
1 227 387
|
2 963 514
|
|
| Additional Paid In Capital |
2 471 474
|
2 471 474
|
1 872 172
|
1 941 832
|
1 941 832
|
1 941 832
|
1 941 832
|
1 941 832
|
1 941 832
|
1 941 832
|
|
| Other Equity |
213 973
|
265 277
|
368 816
|
405 873
|
427 548
|
459 291
|
510 742
|
702 130
|
743 054
|
616 154
|
|
| Total Equity |
4 877 981
N/A
|
5 034 361
+3%
|
5 169 422
+3%
|
6 343 566
+23%
|
5 880 274
-7%
|
5 875 760
0%
|
5 901 499
+0%
|
6 318 961
+7%
|
6 926 052
+10%
|
8 580 485
+24%
|
|
| Total Liabilities & Equity |
8 179 782
N/A
|
8 999 301
+10%
|
10 121 200
+12%
|
11 291 217
+12%
|
9 984 063
-12%
|
10 119 907
+1%
|
9 834 544
-3%
|
10 731 211
+9%
|
13 030 653
+21%
|
13 546 025
+4%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
174
|
120
|
179
|
288
|
297
|
297
|
301
|
354
|
354
|
359
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
